The Drug Induced Renal Injury Consortium
NCT02159209
Acute Kidney Failure, Acute Kidney Injury
Birmingham, Alabama, United States
View Trial DetailsNCT Number: NCT00780845
The purpose of this study is evaluate clinical outcomes and 30-day mortality after on-pump CABG.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Eight hundred and seventeen patients was enrolled in this series and divided into to groups: Group AKI (-) - patients without acute kidney injury after on-pump CABG. Group AKI (+) - patients with acute kidney injury after on-pump CABG. AKI was defined as an absolute increase in serum creatinine (SCr) of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% (1.5-fold from baseline). The change in SCr concentration was defined as the difference between immediate postoperative concentration and the highest concentration during the stay in ICU. Clinical Outcomes and 30-day mortality was evaluate in this patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
Time frame: 30 days
Hospital de Base
Other
AKIN (Acute Kidney Injury Network): Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02159209
Acute Kidney Failure, Acute Kidney Injury
Birmingham, Alabama, United States
View Trial DetailsNCT06866236
Acute Kidney Injury, Chronic Disease
Pasedena, Texas, United States
View Trial DetailsNCT06351813
Acute Kidney Injury, Critical Illness
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03418181
Dialysis, Female Urogenital Diseases
Stevenage, United Kingdom
View Trial Details